Clinical trial
Erythromycin Versus Neomycin Treatment for Overt Hepatic Encephalopathy: a Double-blind, Randomised, Controlled Trial.
NCT01097811 is registered in ClinicalTrials.gov with UPECLIN HC FM Botucatu Unesp as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Erythromycin Versus Neomycin Treatment for Overt Hepatic Encephalopathy: a Double-blind, Randomised, Controlled Trial.
- Lead sponsor
- UPECLIN HC FM Botucatu Unesp
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- June 30, 2008
- Completion date
- December 31, 2010
- Enrollment
- 20 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.